Dr. Jenny Lynn Lazarus, MD

Dr. Lazarus practices at Docs Medical Group Inc in Redding, California.

Dr. Lazarus' NPI, 1902167901, was assigned on June 6, 2012. Dr. Lazarus graduated from Ross University School of Medicine in 2012. Dr. Lazarus holds California license A168579.

Dr. Lazarus' primary practice is Docs Medical Group Inc, at 100 E Cypress Ave, Redding, CA 96002 in Shasta County. The practice phone is (530) 243-8667.

Dr. Lazarus' primary practice is Docs Medical Group Inc in Redding, California. Dr. Lazarus is also affiliated with Modoc Medical Center. The medical group on file is Docs Medical Group Inc. Dmand AI also links Dr. Lazarus to 3 more medical groups, 1 community health center, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lazarus practices, 4 sites in all. Vendor and product names are available with a free account.

General practice is Dr. Lazarus' primary specialty in the NPI Registry, under taxonomy code 208D00000X. Dmand AI has Dr. Lazarus' licenses on file in 3 states: California, Texas and Michigan.

Dmand AI lists acute skin infection, bronchitis, carpal tunnel syndrome, chronic hypertension, conjunctivitis, ear eustachian tube disorders, hives and joint pain among the conditions Dr. Lazarus treats.

CMS data shows 104 Medicare services from Dr. Lazarus across 4 procedure codes in 2024, for 90 Medicare patients. Medicare paid $8,409 for them. Every service was in an office.

CMS counts 90 Medicare patients who saw Dr. Lazarus in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lazarus' median patient age at 53, with 57% women.

In 2024, Dr. Lazarus wrote 162 Medicare Part D claims for 98 patients. 88% of them were for generic drugs. CMS names the drug for 46 of them, across 2 drugs with 11 or more claims each, at $688 in total drug cost. In 2023, CMS named 45 claims across 3 drugs.

Dmand AI links 10 papers to Dr. Lazarus, published from 2018 to 2022. 2019 was the busiest year, with 3. The most frequent topics are Pancreatic Neoplasms, Tumor Microenvironment and B7-H1 Antigen. Dr. Lazarus' most frequent co-authors are Filip Bednar, MD, Michael I. D'Angelica, MD and Jinru Shia, MD.

CMS Open Payments shows 8 general payments to Dr. Lazarus from 5 drug and device companies from 2019 to 2020. Food and beverage make up the largest share, 100% of the total. Mallinckrodt Enterprises LLC paid the most, $52.

Dmand AI lists 4 awards for Dr. Lazarus, most recently Colorectal Cancer Research Scholar Award in 2019.

Dr. Lazarus graduated from Ross University School of Medicine in 2012. Dr. Lazarus is a member of AAS and SSO.

Dr. Lazarus is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.